Prevalence of hepatitis A among drug users in north-eastern Italy: Is vaccination necessary in low prevalence areas?

Fabio Lugoboni, Gianluca Quaglio, Benedetta Pajusco, Maurizio Foroni, Gianstefano Blengio, Giorgio Talamini, Paolo Mezzelani, Don C. Des Jarlais

Research output: Contribution to journalArticle

Abstract

Background: The authors report on the prevalence of, and risk factors for, hepatitis A virus (HAV) in a group of drug users in Italy. Methods: 404 heroin users were recruited and compared with a control group of 107 subjects in the general population. Results: Drug users born in north-eastern Italy have a prevalence of anti-HAV similar to the control group. A much higher prevalence was found in drug users born in southern Italy. Conclusion: The similar prevalence of anti-HAV in drug users born in north-eastern Italy and in the general population, suggests that their lifestyle does not involve a substantial additional risk of HAV. The much higher prevalence found in drug users born in southern Italy is more likely to be related to infection during infancy.

Original languageEnglish (US)
Pages (from-to)464-466
Number of pages3
JournalEuropean Journal of Public Health
Volume15
Issue number5
DOIs
StatePublished - Oct 2005

Keywords

  • HAV infection
  • HAV vaccination
  • Heroin users

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Prevalence of hepatitis A among drug users in north-eastern Italy: Is vaccination necessary in low prevalence areas?'. Together they form a unique fingerprint.

  • Cite this